{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:38:31Z","timestamp":1778222311025,"version":"3.51.4"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T00:00:00Z","timestamp":1411689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0106072","type":"journal-article","created":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T18:28:00Z","timestamp":1411756080000},"page":"e106072","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists"],"prefix":"10.1371","volume":"9","author":[{"given":"Yaser T.","family":"Bazargani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthonius","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert G. M.","family":"Leufkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aukje K.","family":"Mantel-Teeuwisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,9,26]]},"reference":[{"key":"ref1","unstructured":"WHO (2013) Diabetes programme. Available: http:\/\/who.int\/diabetes\/en\/<\/ext-link>. Accessed 2013 Dec 21."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7861\/clinmedicine.13-1-27","article-title":"Management of diabetes in resource-poor settings","volume":"13","author":"P Grant","year":"2013","journal-title":"Clin Med"},{"key":"ref3","unstructured":"WHO (2013) Diabetes factsheets. Available: http:\/\/who.int\/mediacentre\/factsheets\/fs312\/en\/index.html<\/ext-link>. Accessed 2013 Dec 17."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/S0140-6736(10)60550-8","article-title":"Diabetes in sub-saharan africa","volume":"375","author":"JC Mbanya","year":"2010","journal-title":"Lancet"},{"key":"ref5","first-page":"513","article-title":"Population based study of quality of diabetes care in southern india","volume":"56","author":"A Ramachandran","year":"2008","journal-title":"J Assoc Physicians India"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.2337\/dc06-0783","article-title":"Quality of diabetes care in the middle- and high-income group populace: The delhi diabetes community (DEDICOM) survey","volume":"29","author":"J Nagpal","year":"2006","journal-title":"Diabetes Care"},{"key":"ref7","unstructured":"UN, Resolution adopted by the UN General Assembly. Political declaration of the high-level meeting of the general assembly on the prevention and control of non-communicable disease. Available: http:\/\/www.who.int\/nmh\/events\/un_ncd_summit2011\/political_declaration_en.pdf<\/ext-link>. Accessed 2013 Dec 17."},{"key":"ref8","unstructured":"WHO (2013) GLOBAL ACTION PLAN FOR THE PREVENTION AND CONTROL OF NONCOMMUNICABLE DISEASES 2013\u20132020 (version dated 15 march 2013). http:\/\/www.who.int\/cardiovascular_diseases\/15March2013UpdatedRevisedDraftActionPlanAPPROVEDBYADG.pdf<\/ext-link>. Accessed 2013 Dec 17."},{"key":"ref9","unstructured":"WHO (2013) Selection of essential medicines. Available: http:\/\/www.who.int\/selection_medicines\/en\/<\/ext-link>. Accessed 2013 Dec 17."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e87576","DOI":"10.1371\/journal.pone.0087576","article-title":"Essential medicines are more available than other medicines around the globe","volume":"9(2)","author":"YT Bazargani","year":"2014","journal-title":"PLoS ONE"},{"key":"ref11","unstructured":"WHO (2013) Development of country profiles and monitoring of the pharmaceutical situation in countries. Available: http:\/\/www.who.int\/medicines\/areas\/coordination\/coordination_assessment\/en\/index.html<\/ext-link>. Accessed 2012 Sep 1."},{"key":"ref12","unstructured":"WHO (2012) Pharmaceutical country profile data collection tool. Available: http:\/\/www.who.int\/medicines\/areas\/coordination\/Empty_English_Questionnaire.pdf<\/ext-link>. Accessed 2012 Sep 1."},{"key":"ref13","unstructured":"WHO (2013) National medicines List\/Formulary\/Standard treatment guidelines. Available: http:\/\/www.who.int\/selection_medicines\/country_lists\/en\/index.html<\/ext-link>. Accessed 2012 Sep 1."},{"key":"ref14","unstructured":"Norwegian Institute of Public Health, WHO Collaborating Centre for Drug Statistics Methodology (2012) Anatomical Therapeutic Chemical (ATC) classification system for medicines. Available: http:\/\/www.whocc.no\/atc_ddd_index\/<\/ext-link>. Accessed 2013 April 15."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e000258","DOI":"10.1136\/bmjopen-2011-000258","article-title":"Evaluation of the incremental cost to the national health service of prescribing analogue insulin","volume":"1","author":"SE Holden","year":"2011","journal-title":"BMJ Open"},{"key":"ref16","unstructured":"Institute for Health Metrics and Evaluation (IHME) (2013) Global burden of disease. Available: http:\/\/www.healthmetricsandevaluation.org\/gbd\/visualizations\/gbd-heatmap<\/ext-link>. Accessed 2013 Sep 2."},{"key":"ref17","unstructured":"International Diabetes Federation (2009) Diabetes atlas. 4th ed IDF. Available: www.idf.org\/sites\/\u2026\/IDFDiabetesAtlas4thedition.pdf<\/ext-link>. Accessed 2013 Sep 2."},{"key":"ref18","unstructured":"WHO (2013) WHO regions and the location of the regional offices. Available: http:\/\/www.who.int\/about\/regions\/en\/index.html<\/ext-link>. Accessed 2013 April 15."},{"key":"ref19","unstructured":"World Bank (2013) Country classification. Available: http:\/\/data.worldbank.org\/about\/country-classifications<\/ext-link>. Accessed 2013 April 15."},{"key":"ref20","unstructured":"WHO (2013) Diabetes. Available: http:\/\/who.int\/topics\/diabetes_mellitus\/en\/<\/ext-link>. Accessed 2013 Oct 7."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1748-0361.2009.00259.x","article-title":"Diabetes burden and access to preventive care in the rural united states","volume":"26","author":"S Krishna","year":"2010","journal-title":"J Rural Health"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/978-1-4614-5441-0_25","article-title":"Clinical features, diagnostic criteria and pathogenesis of diabetes mellitus","volume":"771","author":"K Imam","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"ref23","unstructured":"WHO (2013) WHO model list of essential medicines, 18th<\/sup> edition. Available: http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/18th_EML_Final_web_8Jul13.pdf<\/ext-link>. Accessed 2013 Oct 7."},{"key":"ref24","unstructured":"National Institute for Health and Clinical Excellence (NICE) clinical guidelines (2004 (revised in 2011)) Type 1 diabetes: Diagnosis and management of type 1 diabetes in children, young people and adults Available: http:\/\/www.nice.org.uk\/nicemedia\/live\/10944\/29390\/29390.pdf<\/ext-link>. Accessed 2013 Dec 2."},{"key":"ref25","unstructured":"International Diabetes Federation (2013) Treatment algorithm for people with type 2 diabetes. Available: http:\/\/www.idf.org\/treatment-algorithm-people-type-2-diabetes<\/ext-link>. Accessed 2013 Oct 7."},{"key":"ref26","unstructured":"Colagiuri S (2012) Global guideline for type 2 diabetes. Brussels, Belgium: International Diabetes Federation (IDF). Available: http:\/\/www.idf.org\/sites\/default\/files\/IDFT2DMGuideline.pdf<\/ext-link>. Accessed 2013 Oct 7."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.amjmed.2009.12.005","article-title":"Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus","volume":"123","author":"L Blonde","year":"2010","journal-title":"Am J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the american diabetes association (ADA) and the european association for the study of diabetes (EASD)","volume":"35","author":"SE Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","article-title":"Management of type 2 diabetes: New and future developments in treatment","volume":"378","author":"AA Tahrani","year":"2011","journal-title":"Lancet"},{"key":"ref30","unstructured":"International Diabetes Federation (2013) Global guideline for type 2 diabetes. Available: http:\/\/www.idf.org\/guidelines\/managing-older-people-type-2-diabetes<\/ext-link>. Accessed 2013 Sep 12."},{"key":"ref31","first-page":"S1","article-title":"The 2012 SEMDSA guideline for the management of typt 2 diabetes","volume":"17","author":"A Amod","year":"2012","journal-title":"Journal of endocrinology, metabolism and diabetes of South Africa (JEMDSA)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/EJE-13-0299","article-title":"Mortality outcomes of different sulphonylurea drugs: The results of a 14-year cohort study of type 2 diabetic patients","volume":"169","author":"S Bo","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1517\/14656566.2012.705829","article-title":"Overview of metformin: Special focus on metformin extended release","volume":"13","author":"S Ali","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"RR Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"ref35","first-page":"20","article-title":"Diabetes update: New drugs to manage type 2 diabetes","volume":"408","author":"DR Erlich","year":"2013","journal-title":"FP Essent"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/JRS-120581","article-title":"Drug utilization, safety and clinical use of actos and avandia","volume":"25","author":"DH Marks","year":"2013","journal-title":"Int J Risk Saf Med"},{"key":"ref37","unstructured":"WHO (2011) REVIEW OF THE EVIDENCE COMPARING INSULIN (HUMAN OR ANIMAL) WITH ANALOGUE INSULINS. Available: http:\/\/www.who.int\/selection_medicines\/committees\/expert\/18\/applications\/Insulin_review.pdf<\/ext-link>. Accessed 2013 Oct 7."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00125-010-1897-3","article-title":"The insulin dilemma in resource-limited countries. A way forward?","volume":"54","author":"GV Gill","year":"2011","journal-title":"Diabetologia"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Beran D, Abdraimova A, Akkazieva B, McKee M, Balabanova D, et al.. (2012) Diabetes in kyrgyzstan: Changes between 2002 and 2009. Int J Health Plann Manage. 10.1002\/hpm.2145; 10.1002\/hpm.2145.","DOI":"10.1002\/hpm.2145"},{"key":"ref40","unstructured":"Richter B, Neises G () Human insulin versus animal insulin in people with diabetes mellitus; cochrane summaries. Available: http:\/\/summaries.cochrane.org\/CD003816\/human-insulin-versus-animal-insulin-in-people-with-diabetes-mellitus<\/ext-link>. Accessed 2013 Oct 7."},{"key":"ref41","unstructured":"Cost of drugs\/Insulin. Available: http:\/\/www.diabetes.co.uk\/diabetes-forum\/viewtopic.php?f=26&t=20655&p=187340&hilit=cost+of+drugs%2Finsulin#p187346<\/ext-link>. Accessed 2013 Sep 12."},{"key":"ref42","unstructured":"Quick B (2011) Human vs. non-human insulin. Available: http:\/\/www.healthcentral.com\/diabetes\/c\/110\/132323\/human-insulin\/<\/ext-link>. Accessed 2013 Sep 12."},{"key":"ref43","unstructured":"Management Sciences for Health (2012) International drug price indicator guide. Available: http:\/\/erc.msh.org\/dmpguide\/index.cfm?search_cat=yes&display=yes&module=dmp<\/ext-link>. Accessed 2014 Jan 12."},{"key":"ref44","unstructured":"IQWiG (2005) Long-acting insulin analogues in the treatment of diabetes mellitus type 1: Executive summary of final report A05-01, version 1.0. In: Anonymous Institute for Quality and Efficiency in Health Care: Executive Summaries. Cologne, Germany. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0033995\/<\/ext-link>. Accessed 2013 Oct 7."},{"key":"ref45","unstructured":"IQWiG (2005) Long-acting insulin analogues in the treatment of diabetes mellitus type 2: Executive summary of final report A05-03, version 1.1. In: Anonymous Institute for Quality and Efficiency in Health Care: Executive Summaries. Cologne, Germany. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0033999\/<\/ext-link>. Accessed 2013 Oct 7."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1517\/14656566.2012.738196","article-title":"Combination of glibenclamide-metformin HCl for the treatment of type 2 diabetes mellitus","volume":"13","author":"EM Lamos","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/11534660-000000000-00000","article-title":"Antidiabetic oral treatment in older people: Does frailty matter?","volume":"26","author":"AM Abbatecola","year":"2009","journal-title":"Drugs Aging"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diabres.2010.03.029","article-title":"Looking beyond the issue of access to insulin: What is needed for proper diabetes care in resource poor settings","volume":"88","author":"D Beran","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2471\/BLT.10.084327","article-title":"Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries","volume":"89","author":"A Cameron","year":"2011","journal-title":"Bull World Health Organ"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2471\/BLT.06.033647","article-title":"The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries","volume":"85","author":"S Mendis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"ref51","unstructured":"WHO (2013) WHO framework for access to essential medicines. Available: http:\/\/www.who.int\/medicines\/areas\/access\/en\/<\/ext-link>. Accessed 2013 Dec 12."},{"key":"ref52","doi-asserted-by":"crossref","first-page":"d5782","DOI":"10.1136\/bmj.d5782","article-title":"The prickly problem of access to insulin","volume":"343","author":"D Cohen","year":"2011","journal-title":"BMJ"},{"key":"ref53","unstructured":"Health Action International (2010) Life-saving insulin largely unaffordable: A one day snapshot of the price of insulin across 60 countries. Available: http:\/\/www.haiweb.org\/medicineprices\/07072010\/Global_briefing_note_FINAL.pdf<\/ext-link> 2014 Jan 12."},{"key":"ref54","unstructured":"Beran D, Higuchi M (2012) How to investigate access to care for chronic non-communicable diseases in low- and middle-income countries: http:\/\/www.access2insulin.org\/uploads\/4\/9\/1\/0\/4910107\/who_ncd_manual_november_2012_version.pdf<\/ext-link>. Accessed 2013 Sep 15."},{"key":"ref55","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2471\/BLT.07.048710","article-title":"Access to medicines versus access to treatment: The case of type 1 diabetes","volume":"86","author":"D Beran","year":"2008","journal-title":"Bull World Health Organ"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(06)69704-3","article-title":"Diabetes care in sub-saharan africa","volume":"368","author":"D Beran","year":"2006","journal-title":"Lancet"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"22258","DOI":"10.3402\/gha.v6i0.22258","article-title":"Constraints faced by urban poor in managing diabetes care: Patients' perspectives from south india","volume":"6","author":"U Bhojani","year":"2013","journal-title":"Glob Health Action"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1010539511412177","article-title":"Delivering diabetes care in the philippines and vietnam: Policy and practice issues","volume":"25","author":"D Beran","year":"2013","journal-title":"Asia Pac J Public Health"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0106072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T01:39:15Z","timestamp":1598319555000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0106072"}},"subtitle":[],"editor":[{"given":"Alberico","family":"Catapano","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,26]]},"references-count":58,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0106072","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,26]]}}}